Merck & Company (DE:6MK)

XETRA:6MK

6MK

Merck & Company

RESEARCH TOOLSreports

Compare Merck & Company (6MK) vs. Competitors

69 Followers

Comparison Results

6MK

Merck & Company

€103.80

€256.88B

14.46

48.80%

13 Buy

7 Hold

0 Sell

Moderate Buy

Gilead Sciences

$138.99

$172.52B

17.94

34.16%

17 Buy

5 Hold

0 Sell

Strong Buy

Novartis

$154.05

$280.58B

19.02

43.67%

3 Buy

3 Hold

0 Sell

Moderate Buy

Pfizer

$26.92

$153.13B

18.21

24.78%

8 Buy

13 Hold

2 Sell

Moderate Buy

Sanofi

$46.76

$112.83B

-31.42

-8.82%

1 Buy

1 Hold

0 Sell

Moderate Buy

AstraZeneca

14988.00 p

£236.19B

28.13

49.76%

13 Buy

2 Hold

1 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs AZN

xxxxxxxxxxxxx

Performance Comparison

DE:6MK

Merck & Company

102.08

34.52

51.09%

GILD

Gilead Sciences

139.03

35.29

34.02%

NVS

Novartis

154.47

47.11

43.88%

PFE

Pfizer

27.34

6.72

32.57%

SNY

Sanofi

46.96

-3.28

-6.53%

GB:AZN

AstraZeneca

14,988.00

4,844.78

47.76%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >